Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Biotechnology
|GILD||Gilead Sciences, Inc.||0.06%||63.22||1.0%||$531.81m|
|VRTX||Vertex Pharmaceuticals, Inc.||-3.62%||252.35||1.9%||$444.70m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.25%||659.20||2.6%||$412.80m|
|SNSS||Sunesis Pharmaceuticals, Inc.||-2.86%||2.04||0.7%||$142.60m|
|EXAS||EXACT Sciences Corp.||-3.90%||52.00||17.7%||$139.49m|
|BMRN||BioMarin Pharmaceutical, Inc.||-1.19%||78.18||4.2%||$97.71m|
|TXG||10X Genomics, Inc.||-4.31%||47.33||0.0%||$92.15m|
22nd Century Group, Inc. is a biotechnology company, which develops disruptive plant-based solutions the for life science, consumer product, and pharmaceutical markets. It focuses on technologies that alter the level of nicotine in tobacco plants and the level of cannabinoids in hemp or cannabis plants through genetic engineering, gene-editing, and modern plant breeding techniques. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.